| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | 10% Owner | Director, 10% Owner
5 companies
Tullis James L L is a Director at ECOR, with reported holdings spanning 5 companies. Recent filings cover 9 purchases and 56 sales. Those positions are worth an estimated $15.6M at current prices.
Our model assigns Tullis James L L a strong insider score of 73/100, based on 18 past trades. Over a 12-month horizon, 77.8% of those trades were profitable, with an average 12-month return of +28.9%.
Tullis James L L's largest disclosed position is in ATEC as Director, worth about $8.3M. The recent filings there lean toward selling, a net 622,596 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 | XGN Exagen Inc. | Director | Sell | 6,800 | $10.72 | $72,862.68 | -0.4% | +14.3% | -39.6% | |
| Aug 4, 2021 | XGN Exagen Inc. | Director | Sell | 8,200 | $11.71 | $95,989.37 | -0.5% | +4.3% | -26.9% | |
| Jun 29, 2021 | XGN Exagen Inc. | Director | Sell | 25,000 | $15.28 | $382,110.05 | -1.6% | -5.6% | -62.5% | |
| Mar 9, 2021 | ATEC Alphatec Holdings, Inc. | Director | Sell | 22,500 | $16.24 | $365,400.00 | -4.0% | -14.8% | -32.1% | |
| Feb 26, 2021 | CXT Crane Nxt, Co. | Director | Sale+OE | 1,115 | $84.47 | $94,184.05 | -18.2% | - | - | |
| Feb 23, 2021 | ATEC Alphatec Holdings, Inc. | Director | Sell | 165,276 | $16.51 | $2,728,706.76 | -10.0% | -5.2% | -40.8% | |
| Feb 5, 2021 | XGN Exagen Inc. | Director, 10% Owner | Sell | 3,000 | $17.00 | $51,000.00 | -12.3% | - | - | |
| Jan 19, 2021 | XGN Exagen Inc. | Director, 10% Owner | Sell | 1,271 | $15.52 | $19,723.47 | -5.0% | - | - | |
| Jan 13, 2021 | XGN Exagen Inc. | Director, 10% Owner | Sell | 5,729 | $15.63 | $89,534.46 | -18.3% | - | - | |
| Dec 15, 2020 | XGN Exagen Inc. | Director, 10% Owner | Sell | 12,000 | $12.23 | $146,726.40 | -0.8% | - | - |